Rayonier Advanced Materials (RYAM) Small-Cap Growth Virtual Investor Conference summary
Event summary combining transcript, slides, and related documents.
Small-Cap Growth Virtual Investor Conference summary
3 Feb, 2026Business overview and product focus
Largest global producer of high-purity cellulose specialty products, with unique three-ply paperboard and high-yield maple pulp offerings.
Products serve diverse end uses: food, industrial adhesives, plastics, LCD screens, textiles, hygiene, and sustainable packaging.
Four world-class facilities in the US, Quebec, and France support operations and growth in biomaterials and bioenergy.
Financial performance and sales mix
Revenue guidance for 2024 is $1.6–$1.7 billion, similar to 2023, but EBITDA is expected to rise from $139M in 2023 to ~$190M in 2024.
Improved sales mix: higher-margin cellulose specialty products up, commodity sales down, driving margin and EBITDA growth.
Suspension of the Temiscaming HPC facility reduces commodity exposure and supports profitability.
Strategic initiatives and operational changes
Targeting $70M debt reduction through cash flow and asset sales, with refinancing of senior notes due by January 2026 as a top priority.
Sale of non-core paperboard and high-yield pulp business ongoing, with increased buyer interest after suspending the HPC line.
Asset optimization focuses on operating commodity facilities only when profitable, reducing earnings volatility.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025